Mar 30,2022

Qure.ai raises $40 Million from healthcare investors Novo Holdings and HealthQuad

Qure.ai (Qure) one of the leading health tech firms using Artificial Intelligence (AI) for medical imaging diagnostics, today announced that it has secured $40 million in a funding round led by Novo Holdings and HealthQuad, supported by existing investor MassMutual Ventures. Qure.ai will use the new investment to extend and strengthen its global reach, especially in the US and Europe, and intensify product development for critical care and community diagnostics.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
May 23,2022

Mayo Clinic invests in Ratan Tata-backed cancer care platform Karkinos Healthcare

Karkinos Healthcare, a technology-driven oncology focussed healthcare platform on Sunday said that US-based Mayo Clinic has invested for a minority stake in the company The company didn't disclose the size of the investment. Karkinos said it will deploy the funds for development of innovative healthcare solutions. Mayo Clinic will also nominate a member on the Board of Karkinos as part of this agreement.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 06,2022

Hong Kong-based AI drug discovery firm Insilico closes $60M Series D

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It�s a sign that certain investors are continuing to bet on emerging biotechnologies � which often take longer to prove profitability compared to other verticals � at a time venture funding is cooling. Insilico raised $60 million from new Series D financing from investors, including its existing shareholders Warburg Pincus, B Capital, Qiming Venture Partners, BOLD Capital Partners, Pavilion Capital and new investors, an undisclosed �large, diversified asset management firm on the West Coast of the US� and BHR Investment.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Jun 07,2022

MedTech Innovator Announces Top 50 Startups Selected for the 2022 Cohort in Tenth Year of World's Largest MedTech Accelerator Program

MedTech Innovator, the world's largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization's flagship four-month Accelerator program, featuring medical device, diagnostic, and digital health technologies from around the globe. As 2022 Cohort members, these startups will get unparalleled visibility and access to leading medtech manufacturers, providers, investors, and other industry stakeholders. At the conclusion of the program, MedTech Innovator will award $500,000 in cash and in-kind prizes in the final competition held at The MedTech Conference, powered by AdvaMed in Boston this fall.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 08,2022

French AI biotech startup Owkin gets $80-million shot from Bristol Myers Squibb

Parisian AI biotech unicorn Owkin has brought in $80 million as it partners with the US-based pharmaceutical giant Bristol Myers Squibb on drugs trials. The new partnership could be transformational for patient outcomes and scientific progress, making machine learning solutions an integral part of the clinical trial process. The $80 million will be split between a Series B-1 equity round, led by Bristol Myers Squibb, and up-front fees for clinical trials for cardiovascular drugs using Owkin's technology. The fresh funding brings the company's total raised to over $300 million. Owkin will use the investment to support its data generation strategy in multiple therapeutic areas with a strong focus on multimodal and rich biological data, including the most advanced spatial single-cell omics technologies.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 15,2022

DermaSensor raises $10M as it braces for U.S. launch

DermaSensor announced today that it raised an additional $10 million as it prepares for a commercial launch in the U.S. DermaSensor said the oversubscribed $10 million financing was led by existing investors, including Ceros Capital Markets. With the newly secured funding, the company is hiring for a range of roles, including chief commercial officer.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 27,2022

Syapse Raises $35M in Growth Funding

Syapse, a San Francisco, CA and New York-based evidence company dedicated to advancing real-world care, raised $35M in Growth funding. The round was led by Innovatus Capital Partners, with participation from existing investors including Ally Bridge Group, Merck Global Health Innovation Fund, Northpond Ventures, Revelation Alpine LLC, Safeguard Scientifics, and Social Capital. The company intends to use the funds to expand its focus on providing real-world insights to partners and assist them in improving outcomes for people with cance

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 10,2022

Insilico Medicine Raises $95 million in Series D Financing with New Investment from Prosperity7 Ventures

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $35 million Series D2 round, led by Prosperity7 Ventures, the diversified growth fund of Aramco Ventures, bringing the total raised in Series D financing to $95 million from a global syndicate of investors with expertise in investing in the biopharmaceutical and life sciences sectors. The financing brought in Prosperity7 as a new investor, alongside current investors in the Series D round, including a large, diversified asset management firm on the US West Coast, BHR Partners, Warburg Pincus, B Capital Group, Qiming Venture Partners, Deerfield, Wilson Sonsini Goodrich & Rosati, BOLD Capital Partners and Pavilion Capital. Insilico�s founder and CEO, Alex Zhavoronkov, PhD, also invested in the Series D round.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Aug 31,2022

Treatment Technologies & Insights (TTI) has raised $1.5M

Treatment Technologies & Insights (TTI), a healthcare technology company, has raised $1.5 million USD through a private offering of securities.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 08,2022

Morgan Health turns eye to home care with $20M investment in LetsGetChecked

The healthcare arm of JPMorgan Chase will make a $20 million investment in LetsGetChecked, which provides clinical solutions that allow for convenient management of patient care in the home. The series D-2 round was led by Casdin Capital and Transformation Capital.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING